Search
Learn about
Our Products
Ecosystems
Portfolios
Due Diligence
Funder Prospecting
Log in
Start
for Free
HUMAN VACCINES PROJECT INC
Sign up to claim this org
HUMAN VACCINES PROJECT INC
New York, NY, US
•
501(c)3
•
EIN
47-2364966
•
WWW.HUMANVACCINESPROJECT.ORG
•
Research Institutes & Public Policy Analysis
Regional Funder
HUMAN VACCINES PROJECT INC
Sign up to claim this org
New York, NY, US
•
501(c)3
•
EIN
47-2364966
•
WWW.HUMANVACCINESPROJECT.ORG
•
Research Institutes & Public Policy Analysis
Regional Funder
Overview
Programs
990s
Income Statement
Balance Sheet
How to Apply
Sign up
for more:
People
Board & Team
Financials
Financial Trends
Funding
Funders
Grants Received
Grantmaking
Giving Insights
Grantees
Grants Given
Overlap
Hide details
Income Statement
Fiscal Year Start:
Jan 1
Revenues in
2024
$1,774,377
Contributions
>99%
Government Grants
0%
Fundraising Events
0%
Program Services
0%
Membership Dues
0%
Investments
0%
Other
0%
Expenses in
2024
$2,264,932
Salaries & Benefits
38%
Fees to Service Providers
32%
Grants
24%
Other
4%
Offices, Occupancy & IT
2%
Benefits to Members
0%
Advertising & Promotion
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$3,030,249
$1,774,377
-41%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$14,846
$0
-100%
Other
-$13,674
$0
-100%
Total Revenues
$3,031,421
$1,774,377
-41%
Expenses
2023
2024
Change
Grants
$878,816
$542,533
-38%
Benefits to Members
$0
$0
-
Salaries & Benefits
$1,194,652
$858,790
-28%
Fees to Service Providers
$715,363
$724,093
+1%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$86,116
$56,375
-35%
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$318,440
$83,141
-74%
Total Expenses
$3,193,387
$2,264,932
-29%
Net income
2023
2024
Change
Net income
-$161,966
-$490,555
-203%
Functional Expenses
Summary
2023
2024
Change
Program
$2,283,732
$1,564,156
-32%
Admin
$710,340
$569,660
-20%
Fundraising
$199,315
$131,116
-34%
Total Expenses
$3,193,387
$2,264,932
-29%
Income Statement
